Raphael Pharmaceutical Inc. (RAPH)

CIK 1415397 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Raphael Pharmaceutical Inc..

Recent SEC filings

FiledFormAccession number
Sep 1, 20268-K0001213900-26-096113
Aug 14, 202610-Q0001213900-26-089975
Jul 17, 20268-K0001213900-26-078937
May 14, 202610-Q0001213900-26-056181
Apr 6, 202640001213900-26-040590
Mar 31, 202610-K0001213900-26-037402
Mar 24, 20268-K0001213900-26-033507
Nov 13, 202510-Q0001213900-25-109968
Sep 8, 202530001213900-25-085537
Aug 13, 202510-Q0001213900-25-075662
Aug 11, 20258-K0001213900-25-074293
Aug 11, 20258-K0001213900-25-073909
May 15, 202510-Q0001213900-25-043641
Mar 31, 202510-K0001213900-25-026214
Mar 12, 202540001213900-25-023367
Mar 11, 202540001213900-25-022736
Mar 6, 202540001213900-25-021172
Feb 13, 202530001213900-25-013687
Jan 14, 20258-K0001213900-25-003401
Dec 30, 20248-K0001213900-24-113467
Nov 21, 2024424B30001213900-24-100968
Nov 14, 202410-Q0001213900-24-098456
Sep 26, 2024EFFECT9999999995-24-002976
Sep 13, 2024S-10001213900-24-078562
Sep 11, 20248-K0001213900-24-077706